Related Experiment Video
Updated: Jul 17, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
A novel Three-miRNA diagnostic signature for tuberculosis: Non-invasive detection and stratification from latent to
Abdulrahman M Tulab1, Essam Mohammed Abdullah2, Haitham N Eyada1
1College of Medicine, Anbar University, Iraq.
Background:
Tuberculosis (TB) is the leading infectious killer and about a quarter of the world's population is estimated to have latent TB infection (LTBI). Present diagnostics do not convincingly separate latent from active TB cases; thus, there is an urgent need for new biomarkers to facilitate accurate diagnosis and risk stratification.
Objectives:
This study seeks the development and validation of a three-microRNA signature consisting of miR-29a, miR-144, and miR-199a in the diagnosis and risk stratification of tuberculosis (TB), gradients of expression across the spectrum be established cut-off values that would work optimally to assist clinical decision-making.
Materials And Methods:
A cross-sectional study was carried out on 100 participants comprising 30 healthy controls (HC), 35 with latent tuberculosis infection (LTBI), and 35 patients suffering from active TB. Quantification of microRNA expression levels was done using real-time polymerase chain reaction (PCR). The diagnostic accuracy of this microRNA signature was determined through ROC curve analysis. The applied statistical methods were ANOVA, post hoc testing, and correlation analysis.
Results:
The three-microRNA signature showed graded expression across the spectrum of TB. MiR-29a revealed maximum differences in expression levels between groups (HC: 1.200 ± 0.485, LTBI: 2.644 ± 1.729, Active TB: 7.380 ± 6.138; p < 0.001). MiR-144 and miR-199a have followed a similar pattern of expression. The combined microRNA signature has excellent diagnostic accuracy with an area under the curve (AUC) of 0.92 for the separation of active TB from LTBI, and good performance yielding an AUC of 0.84 when distinguishing LTBI from healthy control.
Conclusion:
The three-microRNA signature represents a promising non-invasive blood-based approach for differentiating healthy controls, LTBI, and active TB in this single-center cross-sectional study. The observed expression gradients and diagnostic performance support further evaluation in larger, independent, multi-center cohorts.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis